J Mov Disord.  2024 Jul;17(3):328-332. 10.14802/jmd.24061.

Evaluating the Validity and Reliability of the Korean Version of the Scales for Outcomes in Parkinson’s Disease–Cognition

Affiliations
  • 1Department of Neurology, Heundae Paik Hospital, Inje University College of Medicine, Busan, Korea
  • 2Department of Neurology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea
  • 3Depratment of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
  • 4Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
  • 5Department of Neurology, Kyung Hee University Medical Hospital, Kyung Hee University College of Medicine, Seoul, Korea
  • 6Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
  • 7Department of Neurology, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea
  • 8Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
  • 9Department of Neurology and Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 10Department of Neurology, Hallym University College of Medicine, Anyang, Korea
  • 11Department of Neurology, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea
  • 12Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
  • 13Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 14Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  • 15Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
  • 16Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
  • 17Department of Neurology, Gachon University Gil Meidcal Center, Gachon University College of Medicine, Incheon, Korea
  • 18Department of Neurology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea
  • 19Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea
  • 20Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea
  • 21Brainup Neurology Clinic, Daejeon, Korea
  • 22Department of Neurology, Ewha Womans University Seoul Hospital, Ewha Womans University School of Medicine, Seoul, Korea
  • 23Department of Neurology, Myungju Hospital, Yongin, Korea
  • 24Department of Neurology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea
  • 25Department of Neurology, Bobath Memorial Hospital, Seongnam, Korea
  • 26Department of Neurology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
  • 27Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 28Department of Neurology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
  • 29Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul, Korea
  • 30Department of Neurology, S Pohang Stroke and Spine Hospital, Pohang, Korea
  • 31Department of Neurology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea
  • 32Department of Neurology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea
  • 33Department of Neurology, Seoul Now Hospital, Seongnam, Korea

Abstract


Objective
The Scales for Outcomes in Parkinson’s Disease–Cognition (SCOPA-Cog) was developed to assess cognition in patients with Parkinson’s disease (PD). In this study, we aimed to evaluate the validity and reliability of the Korean version of the SCOPACog (K-SCOPA-Cog).
Methods
We enrolled 129 PD patients with movement disorders from 31 clinics in South Korea. The original version of the SCOPA-Cog was translated into Korean using the translation-retranslation method. The test–retest method with an intraclass correlation coefficient (ICC) and Cronbach’s alpha coefficient were used to assess reliability. Spearman’s rank correlation analysis with the Montreal Cognitive Assessment-Korean version (MOCA-K) and the Korean Mini-Mental State Examination (K-MMSE) were used to assess concurrent validity.
Results
The Cronbach’s alpha coefficient was 0.797, and the ICC was 0.887. Spearman’s rank correlation analysis revealed a significant correlation with the K-MMSE and MOCA-K scores (r = 0.546 and r = 0.683, respectively).
Conclusion
Our results demonstrate that the K-SCOPA-Cog has good reliability and validity.

Keyword

Parkinson’s disease; Dementia; Neurocognitive test; Validation study
Full Text Links
  • JMD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr